Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Azithromycin's interactions differ by formulation and by drug. Here is what the actual pharmacokinetic and outcomes research shows.
Azithromycin, clarithromycin, and erythromycin share one ribosomal target but differ sharply in chemistry, dosing, and safety.
A clinically grounded look at how respiratory illness spreads at home, what hand hygiene evidence actually shows, and where materials like silver and chitosan fit.
Azithromycin remains useful for community-acquired pneumonia, but rising resistance has narrowed its role. Here's what current guidelines and evidence show.
Silver has shaped burn and wound care since the 1960s. Here's the real science behind it, the honest limits of the evidence, and where chitosan and chelated silver fit today.
Azithromycin's unusual chemical design gives it real staying power on the shelf. Here is what the evidence shows about storage, expiration, and stability.
Prescription and over-the-counter drug labels follow strict FDA formats. Here is how to read every section and understand what the warnings are actually telling you.
River blindness destroys sight through inflammation, not the worm itself. A single annual dose of ivermectin breaks that cycle before damage occurs.
Four decades of clinical use and mass deworming campaigns have generated an unusually deep safety record for mebendazole, with clear findings and honest limits.